Epidemiology of Lung Cancer: Smoking, Secondhand Smoke, and Genetics

Surgical Oncology Clinics of North America

Volumn 20, Issue 4, 2011, Pages 605-618

  Steliga, Matthew A ^a   Dresler, Carolyn M ^b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b ARKANSAS DEPARTMENT OF HEALTH   (United States)

Author keywords

Epidemiology; Genetics; Lung cancer; Secondhand smoke; Smoking; Tobacco

Indexed keywords

ACETALDEHYDE; ACYLTRANSFERASE; ARSENIC; ASBESTOS; BENZENE; CHROMIUM; COAL; CYTOCHROME P450 1A1; CYTOCHROME P450 2E1; EPIDERMAL GROWTH FACTOR RECEPTOR; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1; K RAS PROTEIN; NICKEL; NICOTINE; NITROSAMINE; POLYCYCLIC AROMATIC HYDROCARBON DERIVATIVE; PROTEIN P21; PROTEIN P53; PROTEIN P73;

BEHAVIOR GENETICS; CANCER GENETICS; CANCER MORTALITY; CANCER RISK; CANCER STAGING; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; LUNG CANCER; LUNG CARCINOGENESIS; MOLECULAR EPIDEMIOLOGY; OVERALL SURVIVAL; PASSIVE SMOKING; REVIEW; SURVIVAL RATE;

HUMANS; LUNG NEOPLASMS; RISK FACTORS; SMOKING; TOBACCO SMOKE POLLUTION;

EID: 80053908784     PISSN: 10553207     EISSN: 15585042     Source Type: Journal    
DOI: 10.1016/j.soc.2011.07.003     Document Type: Review

References (27)

1. U.S.Department of Health and Human Services How tobacco smoke causes disease: the biology and behavioral basis for smoking-attributable disease: a report of the surgeon general 2010, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Atlanta (GA), p. 225, 246, 294-6.
2. Ochsner A., DeBakey M. Primary pulmonary malignancy; treatment by total pneumonectomy; analysis of 79 collected cases and presentation of 7 personal cases. Surg Gynecol Obstet 1939, 68:435-451.
3. McKinnell R.G. Epidemiology. The biological basis of cancer 2006, 229-230. Cambridge University Press, New York. 2nd edition. R.G. McKinnell, R.E. Parchment, A.O. Perantoni (Eds.).
4. U.S.Department of Health, Education, and Welfare Smoking and health: report of the advisory committee to the Surgeon General of the Public Health Service 1964, PHS publication number 1103, U.S. Department of Health, Education, and Welfare, p. 149-61.
5. Surveillance Epidemiology and End Results: Providing information on cancer statistics to help reduce the burden of this disease on the U.S. population. National Cancer Institute: U.S. National Institutes of Health. Available at: Accessed March 12, 2011. http://seer.cancer.gov/faststats/index.php.
6. Lopez A.D., Collishaw N.E., Piha T. A descriptive model of the cigarette epidemic in developed countries. Tobacco Control 1994, 3:242-247.
7. Barnoya J., Glantz S. Association of the California tobacco control program with declines in lung cancer incidence. Cancer Causes Control 2004, 15:689-695.
8. U.S.Department of Health and Human Services The health consequences of involuntary exposure to tobacco smoke: a report of the Surgeon General. Secondhand smoke what it means to you 2006, U.S. Rockville (MD): Department of Health and Human Services, Center for Disease Control and Prevention, Coordinating Center for Health Promotion, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, p. 11.
9. MacLure M., Katz R.B.A., Bryant M.S., et al. Elevated blood levels of carcinogens in passive smokers. Am J Public Health 1989, 79:1381-1384.
10. Schottenfield D. The etiology and epidemiology of lung cancer. Principles and Practice of Lung Cancer: the official reference text of the IASLC 2010, Lippincott Williams and Wilkins, Philadelphia, p. 7-8. 4th edition.
11. Hammond E.C., Selikoff I.J., Lawther P.L., et al. Inhalation of benzpyrene and cancer in man. Ann N Y Acad Sci 1976, 271:116-124.
12. Lubin J.H., Boice J.D. Lung cancer risk from residential radon: metaanalysis of eight epidemiologic studies. J Natl Cancer Inst 1997, 89:49-57.
13. Thomas P.D., Mi H., Swan G.E., Pharmacogenetics of Nicotine Addiction and Treatment Consortium, et al. A systems biology network model for genetic association studies of nicotine addiction and treatment. Pharmacogenet Genomics 2009, 19:538-551.
14. Lerman C.E., Schnoll R.A., Munafò M.R. Genetics and smoking cessation: improving outcomes in smokers at risk. Am J Prev Med 2007, 33(Suppl 6):S398-S405.
15. Ray R., Tyndale R.F., Lerman C. Nicotine dependence pharmacogenetics: role of genetic variation in nicotine-metabolizing enzymes. J Neurogenet 2009, 23(3):252-261.
16. Benowitz N.L., Hukkanen J., Jacob P. Nicotine chemistry, metabolism kinetics and biomarkers. Handb Exp Pharmacol 2009, 192:29-60.
17. Johnstone E., Benowitz N., Cargill A., et al. Determinants of the rate of nicotine metabolism and effects on smoking behavior. Clin Pharmacol Ther 2006, 80(4):319-330.
18. Siu E.C., Tyndale R.F. Non-nicotinic therapies for smoking cessation. Annu Rev Pharmacol Toxicol 2007, 47:541-564.
19. McWilliams J.E., Sanderson B.J., Harris E.L., et al. Glutathione S-Transferase M1 (GSTM1) deficiency and lung cancer risk. Cancer Epidemiol Biomarkers Prev 1995, 4:589-594.
20. Bennet W.P., Alavanja M.C., Biomeke B., et al. Environmental tobacco smoke, genetic susceptibility, and risk of lung cancer in never-smoking women. J Natl Cancer Inst 1999, 91(23):2009-2014.
21. Soda M., Choi Y.L., Enomoto M., et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 2007, 448:561-566.
22. Lynch T.J., Bell D.W., Sordella R., et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung caner to gefitinib. N Engl J Med 2004, 250(21):2129-2139.
23. Lee S.Y., Kim J.K., Jin G., et al. Somatic mutations in epidermal growth factor receptor signaling pathway genes in non-small cell lung cancers. J Thorac Oncol 2010, 5:1734-1740.
24. Gerber D.E., Minna J.D. ALK inhibition for non-small cell lung cancer: from discovery to therapy in record time. Cancer Cell 2010, 18(6):548-551.
25. Brennan P., Hainaut P., Boffetta P. Genetics of lung cancer susceptibility. Lancet Oncol 2011, 12(4):399-408.
26. Lissowska J., Foretova L., Da{ogonek}bek J., et al. Family history and lung cancer risk: international multicentre case-control study in Eastern and Central Europe and meta-analyses. Cancer Causes Control 2010, 21:1091-1104.
27. D'Amelio A.M., Cassidy A., Asomaning K., et al. Comparison of discriminatory power and accuracy of three lung cancer risk models. Br J Cancer 2010, 103:423-429.